Article
Minor Transplacental Passage of Fondaparinux in Vivo
28 Apr 2004
Abstract excerpt
To the Editor: Low-molecular-weight heparin remains the anticoagulant of choice for pregnant women with previous thromboembolic events. Fondaparinux (Arixtra, Sanofi-Synthelabo) is a chemically synthesized derivative of the natural pentasaccharide sequence that mediates the interaction of heparin with antithrombin.1 It has been recommended for prophylaxis against thromboembolism after hip or knee surgery.2,3 My...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
